This Site is Intended for Education Purposes Only

FDA approval is typically required to market stem cells for treating, curing, or preventing diseases. The FDA has only approved using cord blood-derived hematopoietic progenitor cells for specific indications. It is important to note that while stem cell therapies show great promise, the scientific understanding of their potential uses is still in the early stages of development. Using stem cells for any therapeutic purpose requires professional judgment and expertise. We strongly encourage those considering stem cell treatment to consult national health databases and FDA websites to access the most up-to-date information on clinical trials and evaluations of human tissue therapies.

Access to RegenHealthConsultants.com (site) is subject to acceptance and compliance with these Terms, which apply to all visitors and others who access this site. Your access or use of this site indicates your acceptance of these Terms. If you do not agree with any part of these Terms, do not access this site. The site may contain links to third-party websites or services not owned or controlled by us. We assume no responsibility for these third-party websites or services' content, privacy policies, or practices. We reserve the right to modify or replace these Terms at any time at its sole discretion. Contact us with any questions regarding these Terms.